Sector. They are actively engaged in the process and the followon when you talk about a prime boost and the major vaccine, the boost being of followon in other Large Pharma Companies but they invested time and resources and opportunity. And that vaccine shows efficacy. And very much the Public Sector, and very clear this was public good. And the polio vaccines, certainly we expect the lions share of Product Development costs by Public Sectors that would be an equitable one. It comes through investment, engage in the product prices. We get into Licensing Agreements that is part of the licensing agreement. A point about the recent successes of got the, they have brought out Rotavirus Vaccine and h p the vaccine, prices under 5 a dose, h p vaccine under 3 per dose for a Rotavirus Vaccine and additional modeling work we would be bringing offline to put on the web site as soon as we finalize a little bit more. We looked at the cost per regimen in that range including implementation of 30 pe
/PRNewswire/ The "The Telecommunications Industry and Retail of Devices in South Africa 2022" report has been added to ResearchAndMarkets.com s offering..